23 Jul BIOACTIVE AGENT FOR BONE TISSUE ENGINEERING
Abstract
Inventors have discovered a method for inducing bone formation in a patient in need thereof comprising administering an effective amount of benzoyladenosine-3′,5′-cyclic monophosphate (6-Bnz-cAMP) to the patient. Systems for bone tissue engineering, comprising a polymer-based scaffold, such as a PLAGA scaffold and an effective amount of 6-Bnz-cAMP are also disclosed herein.
Year: 2011
Country: US
Doc No: 2011217337